Barstead, 2001, Current opinion in chemical biology, 5, 63, 10.1016/S1367-5931(00)00173-3
Lum, 2003, Science, 299, 2039, 10.1126/science.1081403
2008, Development, 135, 1735, 10.1242/dev.001115
Bill, 2009, 6, 69, 10.1089/zeb.2008.0555
Summerton, 1997, Antisense & nucleic acid drug development, 7, 187, 10.1089/oli.1.1997.7.187
Nasevicius, 2000, Nature genetics, 26, 216, 10.1038/79951
2004, PNAS, 101, 3450, 10.1073/pnas.0400441101
Haffter, 1996, Development, 123, 1, 10.1242/dev.123.1.1
Driever, 1996, Development, 123, 37, 10.1242/dev.123.1.37
2004, PNAS, 101, 12792, 10.1073/pnas.0403929101
Klee, 2004, Nucleic Acids Research, 32, 1414, 10.1093/nar/gkh286
Klee, 2001, Genesis (New York, N.Y. : 2000), 30, 123, 10.1002/gene.1045
Pickart, 2006, 1, e104, 10.1371/journal.pone.0000104
Klee, 2005, BMC bioinformatics [electronic resource], 6, 256, 10.1186/1471-2105-6-256
Knowlton, 2008, BMC bioinformatics [electronic resource], 9, 7, 10.1186/1471-2105-9-7
Ekker, 2004, Methods in cell biology, 77, 121, 10.1016/S0091-679X(04)77007-7
Robu, 2007, 3, e78, 10.1371/journal.pgen.0030078
Ekker, 2001, Genesis (New York, N.Y. : 2000), 30, 89, 10.1002/gene.1038
Gerety, 2011, Developmental biology, 350, 279, 10.1016/j.ydbio.2010.11.030
Woods, 2008, Nature biotechnology, 26, 650, 10.1038/nbt0608-650
Weinstein, 1995, Nature medicine, 1, 1143, 10.1038/nm1195-1143
Eckfeldt, 2005, PLoS biology, 3, e254, 10.1371/journal.pbio.0030254
2008, Briefings in Functional Genomics, 7, 454, 10.1093/bfgp/eln046
Sood, 2006, Methods (San Diego, Calif.), 39, 220, 10.1016/j.ymeth.2006.04.012
2003, Genome Research, 13, 2700, 10.1101/gr.1725103
Doyon, 2008, Nature biotechnology, 26, 702, 10.1038/nbt1409
Doyon, 2008, Nature biotechnology, 26, 695, 10.1038/nbt1398
